Novel Lead Generation Through Hypothetical Pharmacophore Three-Dimensional Database Searching: Discovery of Isoflavonoids as Nonsteroidal Inhibitors of Rat 5α-Reductase

    October 2001 in “ Journal of Medicinal Chemistry
    Grace Shiahuy Chen, Chung-Liang Chang, Wai Ming Kan, Chih-Long Chang, K. C. Wang, Ji-Wang Chern
    Image of study
    TLDR Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.
    In 2001, researchers used a hypothetical pharmacophore model to identify new nonsteroidal inhibitors of rat 5α-reductase, an enzyme associated with several conditions including androgenic alopecia. They screened a database with a pharmacophore generated from 16 different compounds, which led to the discovery of eight isoflavone derivatives as potential inhibitors. These derivatives were categorized based on their inhibitory concentration (IC50) values, with the first category (19a-d) showing IC50 values between 10-27 nM and the second category (19e-h) showing IC50 values of 0.4-23 µM. However, the actual IC50 values against rat 5α-reductase ranged from 6.9-49 µM, which was less potent than existing inhibitors. The study highlights the potential of these derivatives as 5α-reductase inhibitors, despite lower efficacy in rats, and suggests that further testing on human 5α-reductase is necessary. The research illustrates the utility of pharmacophore modeling and 3D database searching in drug discovery, and acknowledges financial support from the National Science Council and the National Health Research Institutes of the Republic of China.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 94 results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 4 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Massive study on finasteride side effects released

      in Finasteride/Dutasteride  83 upvotes 2 years ago
      The release of a study on 5a-reductase inhibitors (finasteride and dutasteride) which showed an increased risk of depression, dementia, decreased libido, and reduced semen load as potential side effects; discussion around other forms of hair loss treatments such as topical minoxidil, RU58841, or opting to accept baldness; and advice to consider professional help for deeper issues related to hair loss.

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  42 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

      community DHT/Testosterone levels in scalp Fin VS Dut.

      in Finasteride/Dutasteride  60 upvotes 5 months ago
      Dutasteride raises scalp testosterone by 99%, which may not be ideal for those sensitive to all androgens. Some argue finasteride's balancing act might be better, while others believe dutasteride is superior for hair regrowth.

    Related Research

    1 / 1 results